Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Dyne Therapeutics (NASDAQ:DYN) Holds Near 52-Week Highs Today

Dyne Therapeutics (NASDAQ:DYN) is a Waltham, Massachusetts-based clinical-stage biotechnology company focused on developing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Leveraging its proprietary FORCE platform, which delivers targeted oligonucleotide therapies directly to muscle tissue and the central nervous system, the company …

Vinay Lochav | 05 August 2026

Elanco Animal Health (NYSE:ELAN) Stock Surges Today After Raised Full-Year Guidance

Elanco Animal Health (NYSE:ELAN) is a global animal health company headquartered in Greenfield and Indianapolis, Indiana, that innovates, develops, manufactures, and markets a broad portfolio of products for both companion animals and farm livestock. Its pet health offerings include parasiticides and vaccines like Seresto, …

Vinay Lochav | 05 August 2026

Liquidia (NASDAQ:LQDA) Trades Near All-Time Highs Today on YUTREPIA Momentum

Liquidia (NASDAQ:LQDA) is a Morrisville, North Carolina-based biopharmaceutical company focused on developing, manufacturing, and commercializing therapies for rare cardiopulmonary diseases, particularly pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. Its lead product, YUTREPIA, an inhaled dry powder formulation of treprostinil built …

Vinay Lochav | 05 August 2026

Why Is Perrigo (NYSE:PRGO) Stock Up 12% Pre-Market Today?

Perrigo (NYSE:PRGO) is a Dublin, Ireland-headquartered consumer self-care company founded in 1887, recognized as the largest store-brand over-the-counter provider in the United States and a top 10 OTC company in Europe. Operating through its Consumer Self-Care Americas and Consumer Self-Care International segments, the company …

Nitish Kishor | 05 August 2026

FILSPARI Sales Nearly Double as Travere Therapeutics (NASDAQ:TVTX) Surges 11% Pre-Market

Travere Therapeutics (NASDAQ:TVTX) is a San Diego-based biopharmaceutical company focused on identifying, developing, and delivering therapies for people living with rare kidney and metabolic diseases. Its lead product, FILSPARI (sparsentan), is a once-daily oral medication approved by the FDA for slowing kidney function decline …

Nitish Kishor | 05 August 2026

DaVita (NYSE:DVA) Slides Further Pre-Market as Unchanged Guidance Disappoints

DaVita (NYSE:DVA) is a leading U.S.-based healthcare provider headquartered in Denver, Colorado, specializing in kidney dialysis services and comprehensive renal care for patients suffering from chronic kidney failure and end-stage renal disease. The company operates an extensive network of over 2,600 outpatient dialysis centers …

Nitish Kishor | 05 August 2026

Eli Lilly (NYSE:LLY) Raises Full-Year Guidance as Mounjaro and Zepbound Drive 48% Revenue Growth

Eli Lilly and Company (NYSE:LLY) is a global pharmaceutical company headquartered in Indianapolis, Indiana, dedicated to researching, developing, and commercializing innovative medicines across cardiometabolic health, oncology, immunology, and neuroscience. The company has established dominant market positions with blockbuster products including Mounjaro and Zepbound in …

Nitish Kishor | 05 August 2026

Why Is Medline (NASDAQ:MDLN) Stock Falling Despite a Strong Earnings Beat?

Medline (NASDAQ:MDLN) is the largest provider of medical-surgical products and supply chain solutions in the United States, serving hospitals, surgical centers, physician offices, post-acute care facilities, and nursing homes both domestically and internationally. Founded in 1966 and headquartered in Northfield, Illinois, the company operates …

Nitish Kishor | 05 August 2026

Orthofix Medical (NASDAQ:OFIX) Climbs Ahead of Today's Earnings as CMS Reimbursement Reversal Stays in Focus

Orthofix Medical (NASDAQ:OFIX) is a global medical technology company headquartered in Lewisville, Texas, led by CEO Massimo Calafiore. The company designs, develops, and markets a comprehensive portfolio of musculoskeletal healing solutions, including spinal implants, bone growth therapies, limb reconstruction systems, regenerative biologics, and enabling …

Nitish Kishor | 05 August 2026

$218 Million: BioCryst Pharmaceuticals (NASDAQ:BCRX) Tops Estimates, Shares Gain Pre-Market

BioCryst Pharmaceuticals (NASDAQ:BCRX) is a Durham, North Carolina-based biotechnology company founded in 1986 that leverages structure-guided drug design to discover and develop oral small-molecule and injectable protein therapeutics for rare and serious diseases. Its commercial portfolio is anchored by ORLADEYO (berotralstat), the first oral, …

Nitish Kishor | 05 August 2026
Support

Hi! How can we help you today?

Loading…